MD Anderson Cancer Center

MD Anderson Cancer Center in Houston, part of the University of Texas and founded in 1941, is the largest cancer centre in the world by patient volume and holds NCI comprehensive designation and second place in the Newsweek/Statista oncology ranking. It runs the biggest early-phase trial unit anywhere, the Moon Shots programme, a proton therapy centre and a leading CAR-NK effort with Takeda, and its breast group under Symmans defined the Residual Cancer Burden index used to grade response after neoadjuvant treatment. Nuclide links it to LACC in cervical cancer and the ROAR anaplastic thyroid cohort, to work on the gut microbiome and dietary fibre in immunotherapy response, and to pathways from cancer neuroscience to cachexia. Whether its scale translates into faster answers than smaller centres remains a fair question. The people listed here show who leads which programme.